美国食品药品管理局（FDA）批准了首个仿制药Victoza（利拉鲁肽注射液）18毫克/3毫升，这是一种胰高血糖素样肽-1（GLP-1）受体激动剂，用于作为饮食和运动的辅助手段改善成人和10岁及以上儿童2型糖尿病患者的血糖控制。

Weight loss injections have become incredibly popular in the last year or so. In fact, these medications are so widely used ...

A human-derived, ultra-long-acting GLP-1 injection independently researched and developed by Innogen, a Shanghai-based ...

Two Omaha women lost more than 300 lbs. combined with injections of a GLP-1 drug, which are used increasingly for weight loss ...

A new clinical trial showed promising results in curbing alcohol cravings in individuals with moderate alcohol-use disorder.

More and more Americans are turning to GLP-1 injections to lose weight. FOX 7 Austin's Rebecca Thomas spoke to an Austin ...

Scientists have discovered an antibody treatment that may help prevent both muscle loss and bone density loss in people using ...

历年来，一些超级碗广告因构思巧妙，制作精良，受到的关注度不亚于赛事本身。以至 哪个广告好看也是每年超级碗的看点之一。但今年有一个超级碗广告估计会让诺和诺德、礼来等一众药企如坐针毡：积极推广GLP-1类药物配制药的Hims & ...

Local companies are developing technologies that they hope could replace a painful poke with something that feels more like ...

More and more Americans are turning to GLP-1 injections to lose weight. FOX 7 Austin's Rebecca Thomas spoke to an Austin physician to discuss.